# Sources — Babe Didrikson Zaharias

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Cayleff SE. “Zaharias, Mildred Ella Didrikson [Babe].” *Handbook of Texas Online*, Texas State Historical Association (first published 1976; revised May 11, 2022). Written by Susan E. Cayleff, her biographer. Supports her birth in Port Arthur on June 26, 1911, as the sixth of seven children of the Norwegian immigrants Ole Nickolene and Hannah Marie (Olson) Didriksen, and her change of the spelling of her surname; the family’s move to Beaumont in 1915; the 1932 Olympic gold medals in the javelin and hurdles and the silver in the high jump; her marriage to George Zaharias on December 23, 1938; “In April 1953 Didrikson underwent a colostomy to remove cancerous tissue”; five tournament wins in 1954, including the U.S. Women’s Open; her return to John Sealy Hospital at the University of Texas Medical Branch in June 1955 and the spread of the cancer; the Babe Didrikson Zaharias Fund of September 1955, which financed a tumor clinic at UTMB; her death at John Sealy Hospital on September 27, 1956, at 45, and burial in Beaumont; and her friendship with Betty Dodd from 1950. https://www.tshaonline.org/handbook/entries/zaharias-mildred-ella-didrikson-babe
2. Michals D, ed. “Mildred ‘Babe’ Didrikson Zaharias.” National Women’s History Museum, 2015. Supports her birth date and place, the 1932 Olympic results, her golf career (17 amateur wins in a row between 1943 and 1947, co-founding the LPGA in 1949, the Associated Press Woman Athlete of the Half-Century in 1950), her marriage in December 1938 to George Zaharias, who became her manager, and “In 1953 Didrikson was diagnosed with cancer and underwent surgery including a colostomy”; and that she died of cancer three years after the diagnosis. https://www.womenshistory.org/education-resources/biographies/mildred-zaharias
3. “Zaharias, Babe Didrikson (1911–1956).” *Women in World History: A Biographical Encyclopedia* (Gale), via Encyclopedia.com. Supports the conflicting birth years (1913, 1914 or 1915 in some sources, including the historical marker at her grave; 1911 documented); colon cancer in 1953 and a colostomy; “a dramatic athletic comeback a mere 14 weeks after her surgery”; the Ben Hogan Comeback Player of the Year award for 1954; the return of the cancer in 1955; her “fund and consciousness raising” for cancer and the American Cancer Society certificate of appreciation; and death at John Sealy Hospital in Galveston, which it dates to September 26, 1956. https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/zaharias-babe-didrikson-1911-1956
4. Winters K. “Zaharias, Babe Didrikson.” *Notable Sports Figures* (Gale), via Encyclopedia.com. Supports that she wrote 1914 as her birth year on her 1932 Olympic application while her gravestone and baptismal certificate support 1911; that she was “feeling extremely fatigued” by the end of the 1952 season; that “In April of 1953 she was diagnosed with colon cancer”; the purchase of the Tampa Golf and Country Club and their home in its converted clubhouse; and its quotation of the *New York Times* report of September 28, 1956, which gave her age as 42. https://www.encyclopedia.com/people/sports-and-games/sports-biographies/babe-didrikson-zaharias
5. Babe Didrikson Zaharias Foundation. “The Life and Achievements of Babe Didrikson Zaharias.” Supports “diagnosed with colon cancer in 1953 and had surgery involving a colostomy on April 17, 1953, in Beaumont”; back surgery in 1955 and spread of the cancer by 1956; that she was “one of the first public figures to openly discuss her cancer in an attempt to spread awareness about the disease”; their homes in Denver and Tampa; and her death from cancer at John Sealy Hospital on September 27, 1956, at 45. https://bdzfoundation.com/about-babe-didrikson-zaharias/
6. Wikipedia. “1954 U.S. Women’s Open” and “1953 U.S. Women’s Open,” citing contemporary wire reports. Used for the dates (July 1 to 3, 1954), venue (Salem Country Club, Peabody, Massachusetts) and twelve-stroke margin of her 1954 win; her absence in 1953 “while recovering from surgery for colon cancer”; and back surgery in 1955 that found cancer near her sacrum. https://en.wikipedia.org/wiki/1954_U.S._Women%27s_Open and https://en.wikipedia.org/wiki/1953_U.S._Women%27s_Open
7. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Rectal Cancer (current version), summarized in Benson AB, et al. “NCCN Guidelines Insights: Rectal Cancer, Version 3.2024.” *J Natl Compr Canc Netw* 2024;22(6):366–375 (PMID 39151454). Rectal-protocol MRI and CT staging, mismatch repair testing of every tumor, multidisciplinary review, checkpoint inhibitor immunotherapy for mismatch repair-deficient disease, total neoadjuvant therapy for proficient disease, and watch-and-wait surveillance after a clinical complete response. The NCCN site itself could not be fetched (403), so the PubMed record of the Insights article is cited. https://pubmed.ncbi.nlm.nih.gov/39151454/
2. Scott AJ, et al. “Management of Locally Advanced Rectal Cancer: ASCO Guideline.” *J Clin Oncol* 2024;42(28):3355–3375 (PMID 39116386). Immunotherapy for dMMR/MSI-high tumors; total neoadjuvant therapy for proficient tumors; nonoperative management after a clinical complete response. https://pubmed.ncbi.nlm.nih.gov/39116386/
3. Cercek A, et al. “PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.” *N Engl J Med* 2022;386(25):2363–2376 (PMID 35660797), and Cercek A, et al. “Nonoperative Management of Mismatch Repair-Deficient Tumors.” *N Engl J Med* 2025;392(23):2297–2308 (PMID 40293177). Dostarlimab 500 mg every three weeks for six months, restaging, and watch-and-wait. https://pubmed.ncbi.nlm.nih.gov/35660797/ and https://pubmed.ncbi.nlm.nih.gov/40293177/
4. Schneider BJ, et al. “Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.” *J Clin Oncol* 2021;39(36):4073–4126 (PMID 34724392). Baseline and periodic TSH and free T4, and continuing immunotherapy with thyroid replacement for primary hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/34724392/
5. Tung N, et al. “Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.” *J Clin Oncol* 2024;42(21):2599–2615 (PMID 38759122). Germline multigene testing for colorectal cancer diagnosed under 50 and for mismatch repair-deficient tumors. https://pubmed.ncbi.nlm.nih.gov/38759122/
6. Rex DK, et al. “Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.” *Am J Gastroenterol* 2017;112(7):1016–1030 (PMID 28555630). Colonoscopy every five years from 40, or 10 years before the youngest diagnosis, for people with a first-degree relative diagnosed before 60. https://pubmed.ncbi.nlm.nih.gov/28555630/
7. U.S. Preventive Services Task Force. “Colorectal Cancer: Screening” (May 18, 2021; *JAMA* 2021;325(19):1965–1977, PMID 34003218): screening from 45 (grade B) and from 50 to 75 (grade A). She was 41 and below the screening age. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
8. Hwang JP, et al. Hepatitis B screening before cancer therapy: ASCO Provisional Clinical Opinion Update. *J Clin Oncol* 2020;38(31):3698–3715 (PMID 32716741). https://pubmed.ncbi.nlm.nih.gov/32716741/
9. Oktay K, et al. Fertility Preservation in Patients With Cancer: ASCO Guideline Update. *J Clin Oncol* 2018;36(19):1994–2001 (PMID 29620997). https://pubmed.ncbi.nlm.nih.gov/29620997/
10. Ligibel JA, et al. “Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.” *J Clin Oncol* 2022;40(22):2491–2507 (PMID 35576506). https://pubmed.ncbi.nlm.nih.gov/35576506/
11. CMID: Clinical Monitoring Intelligence Database, colorectal cancer, hypothyroidism and anemia monographs (Aether Forge, 2026): watch-and-wait surveillance (examination and sigmoidoscopy every three to four months, MRI every six months, CEA, CT, colonoscopy at one year), survivorship care, sexual function, ostomy and bowel function; TSH four to eight weeks after a levothyroxine change; and a blood count about four weeks after oral iron with a follow-up ferritin. https://patrickrutledge.github.io/topthirty/
12. U.S. Preventive Services Task Force: depression (2023), breast cancer (2024), cervical cancer (2018), intimate partner violence (2018), unhealthy alcohol use (2018), and the A and B recommendations; Centers for Disease Control and Prevention, Adult Immunization Schedule by Medical Condition; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations, https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html, https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** She died in 1956, so the rule does not apply. The claims are still limited to what the fetched sources state. The USGA article on her 1954 win and Texas Monthly’s profile could not be fetched (403); the *New York Times* obituary was not read and is cited only through the Notable Sports Figures entry’s quotation of it; Susan Cayleff’s biography *Babe* was not read, and her account is used only through her Handbook of Texas entry. Britannica could not be fetched.
- **Name.** She is known as Babe Didrikson Zaharias; her birth name was Mildred Ella Didrikson (the family spelling was Didriksen), and she competed as Didrikson before and after her marriage. Splitting the display name at the last space would make “Babe Didrikson” her given names. The record uses identity.name_parts with given names Mildred Ella and the family name Didrikson Zaharias, so the C-CDA and FHIR names carry her legal given names and both the surname she was famous under and her married surname; the display name and the FHIR name text stay Babe Didrikson Zaharias. The notes call her Ms. Didrikson Zaharias. Aliases are Mildred Ella Didrikson, Mildred Didrikson Zaharias, Babe Didrikson and Babe Zaharias; none appears in another record. “Babe” alone is not an alias.
- **Birth year.** She gave 1914 on her 1932 Olympic application, and some sources and a marker at her grave give 1913 to 1915; the Handbook of Texas, the National Women’s History Museum, her gravestone and baptismal certificate give 1911, which is used (CLM-0002). The 1914 year is recorded as a conflicting alternative. The contemporary *New York Times* report gave her age at death as 42, which reflects the later year.
- **Death date.** September 27, 1956 (Handbook of Texas, foundation, *New York Times* report); Women in World History gives September 26, recorded as a conflicting alternative.
- **Site of her cancer and the operation (R).** Every source read calls it colon cancer and says the operation included a colostomy; none names the operation or gives pathology. Some popular accounts (Texas Monthly, not fetched) call it rectal cancer. That it was a low rectal cancer removed by abdominoperineal resection is recorded as **R**, possible (CLM-0008), because a permanent colostomy in 1953 most often followed that operation; it is linked to the modern diagnosis but not resolved by it. The modern low rectal adenocarcinoma is a teaching choice that fits the documented permanent colostomy.
- **Index age and dates.** The synthetic date of birth is June 26, 1984 (shift 73 years). The index visit on March 16, 2026 maps to March 16, 1953, when she was 41: after the documented fatigue at the end of the 1952 season and before the documented diagnosis in April and the operation on April 17, 1953. All visits map to March to October 1953, within her lifetime; they are not a claim about where she was. The sources place her home at the Tampa Golf and Country Club and her operation in Beaumont; the modern social history uses Tampa.
- **Intake claims.** Only the fatigue at the end of 1952 (CLM-0006) and earlier history appear in the intake documents. The diagnosis and operation (CLM-0007, CLM-0008) are linked to a timeline event dated April 17, 1953, and the 1954 Open, the recurrence, her cancer advocacy and her death to later events.
- **Presenting problem.** Rectal bleeding with a change in bowel habit and a rectal mass (K62.5) is resolved at the diagnosis visit on March 30, 2026, when low rectal adenocarcinoma (C20, both_with_link) is recorded. Iron deficiency anemia from blood loss (D50.0) is recorded at intake and stays active while iron stores are refilled. The intake documents state only what was known then.
- **Mismatch repair status.** The tumor is mismatch repair deficient (loss of MSH2 and MSH6, microsatellite instability high). This was chosen because it is the teaching point that most changes care for a low rectal cancer in a young athlete: PD-1 blockade with dostarlimab offers a high chance of a clinical complete response and organ preservation, sparing the abdominoperineal resection and permanent colostomy she had in 1953, and it puts mismatch repair testing of every colorectal cancer and germline testing under 50 at the center of the episode. About 5 to 10 percent of rectal cancers are mismatch repair deficient, so this is the less common case; the record says so in the teaching objective by naming total neoadjuvant therapy as the standard for proficient tumors.
- **Germline result.** The germline panel is negative and tumor sequencing finds two somatic MSH2 variants, by design: a positive germline result would imply a health fact about her real blood relatives. Her first-degree relatives are still advised to screen early because she had colorectal cancer young; this is a recommendation, not a statement about any of them. No relative is named, and her siblings are referred to only as the people the screening letter is for.
- **Synthetic clinical picture.** All visits, results, imaging, pathology, stage (cT3bN1M0), the regimen (dostarlimab 500 mg every three weeks for nine doses), the responses, the genetic and tumor results, immune-related hypothyroidism and its treatment, her height (168 cm) and weights are synthetic. Qualitative results (biopsy, mismatch repair stains, hepatitis and HIV tests, pregnancy test, genetic results, rapid respiratory tests) are in note text only.
- **Sick visit.** A viral upper respiratory infection (J06.9) a week before cycle 4, chosen because a new cough on PD-1 blockade must prompt a check for pneumonitis (oxygen saturation at rest and on exertion, chest X-ray), because it fits her life on tour, and because it insinuates no undocumented real diagnosis. The TSH drawn that day for two weeks of tiredness showed the first rise of immune-related thyroiditis.
- **Preventive visit.** A periodic adult preventive visit at 42 (CPT 99396 and 99497 in plain text) on the day of cycle 7: hepatitis B vaccination begun (negative surface antibody), first screening mammogram ordered under the 2024 USPSTF recommendation, sun protection counseling and a skin examination for an outdoor athlete, influenza and COVID-19 vaccines due in the autumn, zoster vaccine not indicated (PD-1 blockade alone is not immunosuppressive treatment), and advance care planning with an unnamed agent.
- **Focused visits.** The four chronic-care follow-ups (diagnosis and consultation, cycle 2, restaging after four doses, and final restaging) are documented as focused visits on the NCCN rectal cancer guideline, the ASCO locally advanced rectal cancer, germline testing and immune-related adverse event guidance, the dostarlimab trials, and the CMID colorectal cancer, hypothyroidism and anemia monographs. Synthetic findings introduced: immune-related hypothyroidism (E03.2) at the fourth visit, treated with levothyroxine while dostarlimab continued. Two protocol deviations are recorded instead of invented results: (1) the ferritin due about three months after oral iron began was not drawn at the restaging visit; no harm (bleeding stopped, hemoglobin normal); drawn at the final visit (41 ng/mL); (2) the TSH and free T4 due with the ninth dose, six weeks after the preventive visit, were not drawn; no harm (TSH 2.4 at the final visit on an unchanged dose); corrective action: thyroid tests added to the standing order sets.
- **Wound-ostomy nursing and surgery.** Because she reached a clinical complete response, no operation and no stoma were needed. The colorectal surgery consultation at diagnosis and the contingency plan (chemoradiation and total mesorectal excision, with stoma marking and teaching by a wound-ostomy nurse before any operation) are recorded; the wound-ostomy rows are “not indicated” with the reason.
- **Consultation.** The medical oncology referral and the consultation by Jun-Ho Albright-Nakamura, MD (a fictional consultant), on the diagnosis day, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: mismatch repair-deficient cT3bN1M0 low rectal cancer; dostarlimab for nine doses with restaging, then watch-and-wait after a clinical complete response; germline testing with tumor sequencing when negative, and early screening for first-degree relatives; immune-related adverse event monitoring (thyroiditis occurred and was treated); and continued sport, contraception and sexual health.
- **Real people.** George Zaharias appears only in the documented history (CLM-0004, CLM-0011). Betty Dodd, her close companion from 1950, is documented in the Handbook of Texas; she is not used, because the episode’s social history does not need her. No relative, companion or historical physician is given a role in the modern episode, and no other figure with a record in the dataset is named.
- **Not used.** Accounts that name a surgeon, hospital or Beaumont physician for the 1953 operation were not found in a fetchable reliable source. The Notable Sports Figures entry says she “tied as winner” of the 1954 Open; the Wikipedia biography says she won it a month after surgery; both are wrong against the championship record and are not used. Her alcohol and tobacco use, her private papers and her doctors’ records were not researched.
